1Centers for Disease Control and Prevention. Diabetes lated ampu tation of lower extremities in the Medicare population Minnesota. Morb Mortal Wkly Rep, 1998,47:649-652.
2Reiber GE. The epidemiology of diabetic fot problems. Diabet Med 1998:13:6-11.
1Weiman JT, Smiell JM, Yachin Su. Efficacy and safety of a topical gel formulation of recombinant human platelet - derived growth factor-BB (becaplermin) in patients with chronic neuropathic diabetic deers. Diabetes Care 1998;21:822 - 827.
2Cough A, Clapperton M, Rolando N, et al. Randomised placebocontrolled trial of granuloeyte - colony stimulating factor in diabetic foot infection. Lancet 1997;350:855- 859.
3Centers for Disease Control and Prevention. Diabetes - related amputation of lower extremities in the Medicare population - Minnesota.Morb Mortal Wkly Rep 1998;47:649- 652.
4Lipsky BA. Osteomyelitis of the foot in diabetic patients. Clin Infect Dis 1997;25: 1318- 1326.
5Reiber GE. The epidemiology of diabetic foot problems. Diabet Med 1998;13:6- 11.
6Apelqvist J. Wound healing in diabetes: outcome and costs. Clin Pediatr Med Sur 1998; 15:21 - 39.
7Gerit D, Mulder. Diabetic foot ulcers: old problems- new technologies. Nephrol Dial Transplant 2001 ; 16:695 - 698.
8Margolis DJ, Kantor J, Berlin JA. Healing of diabetic neuropathic foot ulcers receiving standard treatment: a meta - analysis. Diabetes Care 1999;22:692 - 695.
9David G, Armstrong, Hienvu C, et al. Off- loading the diabetic foot wound. Diabetes Care 2001 ;24:1019 - 1022.
10Reiber GE, Vileikyte L, Boyko EJ, et al. Causal pathways for incident lower- extremity ulcers in patients with diabetes from two setting. Diabetes Care 1999;22:157- 162.
